HIGHLIGHTS
- who: Min Hou and collaborators from the Department of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China have published the research work: ThePredictiveValueofThreeVariablesinPatientswithMetastatic Renal Cell Carcinoma Treated with Immune-Based Combination Therapies in Randomized Clinical Trials: A Systematic Review and Meta-Analysis, in the Journal: Journal of Oncology of 10/09/2022
- what: As a result the purpose of this research is to evaluate the potential differences of immune-based combination therapies on survival benefits from mRCC subgroups. If the articles accord with these criteria, they were included in this meta-analysis: RCTs assessing survival . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.